Analyst Report: Amgen Inc
All Analyst Report Argus • May 19, 2026 Amgen Inc.: Raising EPS estimates for 2026 and 2027 Summary Amgen, based in Thousand Oaks, California, is a leading global biotech company. Its key products include Prolia, Enbrel, Otezla, Repatha, Xgeva, Tepezza, Evenity, Blincyto, Kyprolis, Kry Upgrade to begin using premium research reports and get so much
Continue Reading